Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05100862
PHASE3

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Sponsor: BeOne Medicines

View on ClinicalTrials.gov

Summary

The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R\^2) in participants with relapsed/refractory (R/R) follicular lymphoma (FL), as measured by progression-free survival as determined by an independent review committee in accordance with the 2014 modification of the International Working Group on non-Hodgkin lymphoma (NHL) Criteria based on n positron emission tomography and computed tomography (PET/CT), and to compare the efficacy of zanubrutinib plus rituximab versus R\^2 in participants with R/R marginal zone lymphoma (MZL), as measured by progression free survival (PFS) assessed by IRC in accordance with CT-based Lugano 2014 Criteria.

Official title: A Phase 3 Randomized, Open-Label Multicenter Study of Zanubrutinib (BGB-3111) Plus Anti-CD20 Antibodies Versus Lenalidomide Plus Rituximab in Patients With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

799

Start Date

2022-03-10

Completion Date

2030-06

Last Updated

2026-10-15

Healthy Volunteers

No

Interventions

DRUG

Zanubrutinib

Zanubrutinib will be administered orally as two 80-milligram (mg) capsules twice a day (160 mg twice a day) or four 80-mg capsules once a day (320 mg once a day) continuously in repeated 28-day cycles.

DRUG

Rituximab

Rituximab will be administered intravenously at a dose of 375 mg/meter squared on Days 1, 8, 15, and 22 of Cycle 1 and on Day 1 of Cycles 2 to 5. Each cycle is 28 days in length.

DRUG

Lenalidomide

Lenalidomide will be administered orally as 20-mg capsules (10 mg if creatinine clearance ≥ 30 mL/min but \< 60 mL/min) once a day on Days 1 to 21 of each 28-day cycle for a total of 12 cycles.

DRUG

Obinutuzumab

Obinutuzumab will be administered at a dose of 1000 mg on Cycle 1 Days 1, 8, 15 and then on Cycles 2 to 6 Day 1.

Locations (264)

Ucsf Fresno University of California San Francisco Fresno

Fresno, California, United States

Kaiser Permanente Southern California

Irvine, California, United States

Cancer and Blood Specialty Clinic

Los Alamitos, California, United States

Los Angeles Cancer Network

Los Angeles, California, United States

Valkyrie Clinical Trials

Los Angeles, California, United States

UCLA Hematologyoncology

Los Angeles, California, United States

Scripps Health

San Diego, California, United States

Sharp Healthcare Sharp Memorial Hospital

San Diego, California, United States

Baptist Md Anderson Cancer Center

Jacksonville, Florida, United States

Ascension Sacred Heart

Pensacola, Florida, United States

Northwest Georgia Oncology Centers Marietta

Marietta, Georgia, United States

Cancer Care Specialists of Illinois

OFallon, Illinois, United States

Fort Wayne Medical Oncology and Hematology

Fort Wayne, Indiana, United States

Mission Cancer and Blood

Waukee, Iowa, United States

Cotton Oneil Cancer Center

Topeka, Kansas, United States

Cancer Center of Kansas

Wichita, Kansas, United States

Baptist Health Lexington

Lexington, Kentucky, United States

Christus Highland Cancer Treatment Center

Shreveport, Louisiana, United States

Luminis Health Anne Arundel Medical Center

Annapolis, Maryland, United States

The University of Maryland Greenebaum Comprehensive Cancer Center

Baltimore, Maryland, United States

Ascension St Agnes Hospital

Baltimore, Maryland, United States

American Oncology Partners of Maryland Pa

Bethesda, Maryland, United States

Henry Ford Hospital

Detroit, Michigan, United States

Corewell Health the Michigan Cancer Consortium

Grand Rapids, Michigan, United States

Hattiesburg Hematology and Oncology Clinic

Hattiesburg, Mississippi, United States

University of Missouri Hospital Ellis Fischel Cancer Center

Columbia, Missouri, United States

Oncology Hematology Associates

Springfield, Missouri, United States

St Vincent Frontier Cancer Center

Billings, Montana, United States

Nebraska Cancer Specialists

Omaha, Nebraska, United States

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States

Iyengar Hematology Oncology Medical Center Pa

Bayonne, New Jersey, United States

Summit Medical Group

Florham Park, New Jersey, United States

New York Cancer and Blood Specialists

Shirley, New York, United States

Suny Upstate Medical University

Syracuse, New York, United States

North Shore Hematology Oncology Associates Eccc Bronx

The Bronx, New York, United States

Optum Medical Care, Pc

Westbury, New York, United States

Levine Cancer Institute Wake Forest

Charlotte, North Carolina, United States

Oncology Hematology Care Clinical Trials, Llc

Cincinnati, Ohio, United States

Va Northeast Ohio Healthcare System

Cleveland, Ohio, United States

Toledo Clinic Cancer Center

Toledo, Ohio, United States

Mainline Health Lankenau Institute For Medical Research

Wynnewood, Pennsylvania, United States

Cancer Care Associates of York

York, Pennsylvania, United States

Prairie Lakes Healthcare System

Watertown, South Dakota, United States

Tennessee Oncology Nashville St Thomas Midtown Clinic

Nashville, Tennessee, United States

Texas Oncology Baylor Charles A Sammons Cancer Center

Dallas, Texas, United States

Md Anderson Cancer Center

Houston, Texas, United States

Northeast Texas Cancer and Research Institute

Tyler, Texas, United States

University of Washington

Seattle, Washington, United States

Medical Oncology Associates

Spokane, Washington, United States

Northwest Medical Specialties

Tacoma, Washington, United States

Hospital Aleman

Caba, Argentina

Hospital Italiano de Buenos Aires

Ciudad Autonoma Buenos Aires, Argentina

Concord Repatriation General Hospital

Concord, New South Wales, Australia

Gosford Hospital

Gosford, New South Wales, Australia

St George Hospital

Kogarah, New South Wales, Australia

Orange Health Hospital

Orange, New South Wales, Australia

Port Macquarie Base Hospital

Port Macquarie, New South Wales, Australia

Westmead Hospital

Westmead, New South Wales, Australia

Townsville University Hospital

Douglas, Queensland, Australia

Genesiscare North Adelaide

North Adelaide, South Australia, Australia

Monash Health

Clayton, Victoria, Australia

Epworth Freemasons

East Melbourne, Victoria, Australia

St Vincents Hospital Melbourne

Fitzroy, Victoria, Australia

Austin Health

Heidelberg, Victoria, Australia

Cabrini Hospital Malvern

Malvern, Victoria, Australia

The Alfred Hospital

Melbourne, Victoria, Australia

La Trobe Regional Hospital

Melbourne, Victoria, Australia

Royal Perth Hospital

Perth, Western Australia, Australia

Perth Blood Institute

West Perth, Western Australia, Australia

Medizinische Universitatsklinik Innsbruck

Innsbruck, Austria

Uk St Poelten

Sankt Pölten, Austria

Medical Univeristy Vienna

Vienna, Austria

Hanusch Krankenhaus

Vienna, Austria

Wiener Gesundheitsverbund Klinik Ottakring

Vienna, Austria

Institut Jules Bordet

Anderlecht, Belgium

Az Sint Jan Brugge

Bruges, Belgium

Universitair Ziekenhuis Gent

Ghent, Belgium

University Hospitals Leuven

Leuven, Belgium

Hospital de Amor Barretos

Barretos, Brazil

Clinica de Oncologia Reichow

Blumenau, Brazil

Unesp Faculdade de Medicina Da Universidade Estadual Paulista Campus Botucatu

Botucatu, Brazil

Instituto Dor de Pesquisa E Ensino Distrito Federal

Brasília, Brazil

Universidade de Campinas Centro de Hematologia E Hemoterapia

Campinas, Brazil

Fundacao Universidade de Caxias Do Sul

Caxias do Sul, Brazil

Centro Integrado de Oncologia de Curitiba Ss Cionc

Curitiba, Brazil

Hospital Erasto Gaertner

Curitiba, Brazil

Centro de Ensino E Pesquisa Em Oncologia de Santa Catarina (Cepen)

Florianópolis, Brazil

Complexo Hospitalar de Niteroi

Niterói, Brazil

Centro Gaucho Integrado de Oncologia Hospital Mae de Deus

Porto Alegre, Brazil

Instituto Dor de Pesquisa E Ensino Pernambuco

Recife, Brazil

Hospital Das Clinicas Da Faculdade de Medicina de Ribeirao Preto Usp

Ribeirão Preto, Brazil

Instituto Dor de Pesquisa E Ensino Rio de Janeiro

Rio de Janeiro, Brazil

Instituto Americas Ensino, Pesquisa E Inovacao

Rio de Janeiro, Brazil

Hospital Sao Rafael Instituto Dor de Pesquisa E Ensino

Salvador, Brazil

Ensino E Terapia de Inovacao Clinica Amo Etica

Salvador, Brazil

Instituto Dor de Pesquisa E Ensino Sao Paulo

São Paulo, Brazil

Hospital Nove de Julho Dasa

São Paulo, Brazil

Hcfmusp Pesquisa Clinica Do Servico de Hematologia E Terapia Celular

São Paulo, Brazil

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein

São Paulo, Brazil

Hospital Santa Rita de Cassia Afecc

Vitória, Brazil

And 164 more locations on ClinicalTrials.gov